Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDA II: Thymosin α1 in Acute Aortic Dissection Surgery
NCT05339529Completed
- Sponsor
- Nanjing Medical University
- Start
- Jul 2022
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Randomised, open-label trial of thymosin alpha 1 in Acute aortic syndrome (AAS) and aortic dissection (2 arms), sponsored by Nanjing Medical University. Primary endpoint: Sequential Organ Failure Assessment at 7 days. Started Jul 2022; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
Acute aortic syndrome (AAS)aortic dissection
Beyond the preview
Go deeper on NCT05339529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05339529.